BMRN BioMarin Pharmaceutical, Inc.

NASDAQ
$66.70

BioMarin Pharmaceutical, Inc. (BMRN) SEC Filings

Everything BMRN has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

33 filings
Date Form Filing
8-K MATERIAL_AGREEMENT
8-K REG_FD
8-K ACQUISITION_DISPOSITION
8-K GUIDANCE_UPDATE
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.